Health ❯ Healthcare ❯ Patient Safety

Medication Risks

Side Effects Long-term Use Long-term Use Effects Chronic Use of Supplements Adverse Effects Hormonal Medications Arrhythmia Long-term Medication Use Unlicensed Drugs Prescribing Considerations

Nearly 370,000 Bottles of Duloxetine Recalled for Nitrosamine Impurity

Detection of N‑nitroso‑duloxetine above FDA interim limits signals manufacturing quality problems that could increase long‑term cancer risk.

Brazil Bans All Medicines With Clobutinol Over Cardiac Risk

New Data Tie GLP-1 Drugs’ Broad Benefits to Inflammation

Germany Rules No Added Benefit for New Alzheimer Antibodies After Major Review Finds Little Effect

NHS GP Dr Amir Khan Warns Against Sleeping Pills, Urging Rare, Short-Term Use Only

Coroner Warns Apixaban Leaflets Omit Head‑Injury Advice After Death Following Minor Fall

NHS Starts Targeted Mounjaro Prescribing as Norfolk–Waveney ICB Estimates Over 11,000 Eligible

NHS Renews Warnings on PPIs, Sets OTC Pantoprazole Limits

TikTok Pharmacist Warns Against Routine Use of OTC Indigestion Remedies

NHS Guidance on Beclometasone Inhalers Reiterated, Flagging Age Limits and Trace Alcohol in Some Brands

MHRA Issues New Year Warning Against Buying Weight-Loss Jabs From Unregulated Sellers

Unpublished AHA Study Links Long-Term Melatonin Use to Higher Heart Risks

Long-Term Melatonin Use Linked to Higher Heart Failure and Mortality Risk in Large EHR Study

Teva, Amerisource Pull 580,000+ Prazosin Bottles as FDA Flags Nitrosamine Contamination

NHS Reiterates Naproxen Warning Over Rare ‘Burning Stomach’ Ulcer Signs

The Lancet Review Finds Antidepressants Differ Sharply in Weight, Heart Rate and Blood Pressure Effects

GP Warns Against Long-Term Omeprazole Use in UK

Anvisa Approves Dayvigo (Lemborexant) for Adult Insomnia in Brazil

New Trials Challenge Routine Beta-Blocker Use After Heart Attack, With Possible Harm in Women

Spain Urges Caution After REBOOT Trial Finds No Routine Benefit From Beta-Blockers Post-MI